25 XP   0   0   10

Stryker Corporation
Buy, Hold or Sell?

Let's analyse Stryker together

PenkeI guess you are interested in Stryker Corporation. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Stryker Corporation. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Stryker Corporation

I send you an email if I find something interesting about Stryker Corporation.

Quick analysis of Stryker (30 sec.)










What can you expect buying and holding a share of Stryker? (30 sec.)

How much money do you get?

How much money do you get?
€3.00
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
€45.66
Expected worth in 1 year
€50.52
How sure are you?
89.3%

+ What do you gain per year?

Total Gains per Share
€7.66
Return On Investment
2.4%

For what price can you sell your share?

Current Price per Share
€313.80
Expected price per share
€277.65 - €333.60
How sure are you?
50%

1. Valuation of Stryker (5 min.)




Live pricePrice per Share (EOD)

€313.80

Intrinsic Value Per Share

€84.29 - €98.71

Total Value Per Share

€129.95 - €144.38

2. Growth of Stryker (5 min.)




Is Stryker growing?

Current yearPrevious yearGrowGrow %
How rich?$18.5b$15.9b$1.7b9.8%

How much money is Stryker making?

Current yearPrevious yearGrowGrow %
Making money$791.2m$589.4m$201.7m25.5%
Net Profit Margin15.2%12.8%--

How much money comes from the company's main activities?

3. Financial Health of Stryker (5 min.)




4. Comparing to competitors in the Medical Devices industry (5 min.)




  Industry Rankings (Medical Devices)  


Richest
#6 / 334

Most Revenue
#6 / 334

Most Profit
#5 / 334

What can you expect buying and holding a share of Stryker? (5 min.)

Welcome investor! Stryker's management wants to use your money to grow the business. In return you get a share of Stryker.

What can you expect buying and holding a share of Stryker?

First you should know what it really means to hold a share of Stryker. And how you can make/lose money.

Speculation

The Price per Share of Stryker is €313.80. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Stryker.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Stryker, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is €45.66. Based on the TTM, the Book Value Change Per Share is €1.21 per quarter. Based on the YOY, the Book Value Change Per Share is €1.07 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is €0.70 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Stryker.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps3.001.0%2.180.7%1.550.5%1.490.5%1.490.5%
Usd Book Value Change Per Share1.810.6%1.300.4%1.140.4%0.900.3%1.750.6%
Usd Dividend Per Share0.750.2%0.750.2%0.690.2%0.630.2%0.570.2%
Usd Total Gains Per Share2.560.8%2.050.7%1.830.6%1.530.5%2.320.7%
Usd Price Per Share289.06-286.21-232.33-228.19-203.52-
Price to Earnings Ratio24.06-34.18-43.33-27.98-24.65-
Price-to-Total Gains Ratio113.03-145.02-155.20-135.58-103.94-
Price to Book Ratio5.92-6.16-5.56-5.96-5.80-
Price-to-Total Gains Ratio113.03-145.02-155.20-135.58-103.94-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share335.82876
Number of shares2
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.750.63
Usd Book Value Change Per Share1.300.90
Usd Total Gains Per Share2.051.53
Gains per Quarter (2 shares)4.103.06
Gains per Year (2 shares)16.3812.24
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
16106572
2122122101414
3183138152226
4244254202938
5305270253650
6366286304362
74273102355174
84883118405886
95494134456598
10601041505072110

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%12.00.00.0100.0%19.01.00.095.0%26.02.00.092.9%26.02.00.092.9%
Book Value Change Per Share4.00.00.0100.0%12.00.00.0100.0%18.02.00.090.0%24.04.00.085.7%24.04.00.085.7%
Dividend per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%28.00.00.0100.0%28.00.00.0100.0%
Total Gains per Share4.00.00.0100.0%12.00.00.0100.0%19.01.00.095.0%25.03.00.089.3%25.03.00.089.3%

Fundamentals of Stryker

About Stryker Corporation

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical and thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, clinical communication and workflow solutions, and other medical device products that are used in various medical specialties, as well as patient and caregiver safety technologies. This segment also provides neurosurgical, neurovascular and craniomaxillofacial implant products, which include products used for minimally invasive endovascular procedures; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.

Fundamental data was last updated by Penke on 2024-04-05 02:49:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is fair priced.

1.1. Profitability of Stryker Corporation.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Stryker earns for each €1 of revenue.

  • Above 10% is considered healthy but always compare Stryker to the Medical Devices industry mean.
  • A Net Profit Margin of 19.7% means that €0.20 for each €1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Stryker Corporation:

  • The MRQ is 19.7%. The company is making a huge profit. +2
  • The TTM is 15.2%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ19.7%TTM15.2%+4.4%
TTM15.2%YOY12.8%+2.4%
TTM15.2%5Y12.7%+2.5%
5Y12.7%10Y13.9%-1.2%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ19.7%-12.4%+32.1%
TTM15.2%-20.4%+35.6%
YOY12.8%-14.4%+27.2%
5Y12.7%-21.3%+34.0%
10Y13.9%-25.0%+38.9%
1.1.2. Return on Assets

Shows how efficient Stryker is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Stryker to the Medical Devices industry mean.
  • 2.9% Return on Assets means that Stryker generated €0.03 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Stryker Corporation:

  • The MRQ is 2.9%. Using its assets, the company is less efficient in making profit.
  • The TTM is 2.1%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ2.9%TTM2.1%+0.8%
TTM2.1%YOY1.6%+0.4%
TTM2.1%5Y1.7%+0.4%
5Y1.7%10Y1.9%-0.2%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ2.9%-4.1%+7.0%
TTM2.1%-4.7%+6.8%
YOY1.6%-4.6%+6.2%
5Y1.7%-4.0%+5.7%
10Y1.9%-5.2%+7.1%
1.1.3. Return on Equity

Shows how efficient Stryker is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Stryker to the Medical Devices industry mean.
  • 6.1% Return on Equity means Stryker generated €0.06 for each €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Stryker Corporation:

  • The MRQ is 6.1%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 4.4%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ6.1%TTM4.4%+1.7%
TTM4.4%YOY3.7%+0.8%
TTM4.4%5Y3.8%+0.7%
5Y3.8%10Y4.3%-0.5%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ6.1%-4.2%+10.3%
TTM4.4%-5.8%+10.2%
YOY3.7%-5.5%+9.2%
5Y3.8%-6.3%+10.1%
10Y4.3%-7.1%+11.4%

1.2. Operating Efficiency of Stryker Corporation.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Stryker is operating .

  • Measures how much profit Stryker makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Stryker to the Medical Devices industry mean.
  • An Operating Margin of 0.0% means the company generated €0.00  for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Stryker Corporation:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM9.3%-9.3%
TTM9.3%YOY19.0%-9.7%
TTM9.3%5Y18.8%-9.5%
5Y18.8%10Y19.7%-0.8%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ--24.3%+24.3%
TTM9.3%-16.4%+25.7%
YOY19.0%-14.0%+33.0%
5Y18.8%-20.4%+39.2%
10Y19.7%-24.8%+44.5%
1.2.2. Operating Ratio

Measures how efficient Stryker is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Devices industry mean).
  • An Operation Ratio of 1.15 means that the operating costs are €1.15 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of Stryker Corporation:

  • The MRQ is 1.146. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.174. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.146TTM1.174-0.028
TTM1.174YOY1.209-0.035
TTM1.1745Y1.194-0.020
5Y1.19410Y1.143+0.051
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ1.1461.456-0.310
TTM1.1741.439-0.265
YOY1.2091.431-0.222
5Y1.1941.436-0.242
10Y1.1431.374-0.231

1.3. Liquidity of Stryker Corporation.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Stryker is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Devices industry mean).
  • A Current Ratio of 1.58 means the company has €1.58 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of Stryker Corporation:

  • The MRQ is 1.580. The company is able to pay all its short-term debts. +1
  • The TTM is 1.584. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.580TTM1.584-0.003
TTM1.584YOY1.913-0.329
TTM1.5845Y2.099-0.515
5Y2.09910Y2.125-0.027
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ1.5802.693-1.113
TTM1.5842.697-1.113
YOY1.9133.504-1.591
5Y2.0993.617-1.518
10Y2.1253.499-1.374
1.3.2. Quick Ratio

Measures if Stryker is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Stryker to the Medical Devices industry mean.
  • A Quick Ratio of 0.49 means the company can pay off €0.49 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Stryker Corporation:

  • The MRQ is 0.486. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.501. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.486TTM0.501-0.016
TTM0.501YOY0.676-0.174
TTM0.5015Y0.611-0.110
5Y0.61110Y0.609+0.003
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4861.516-1.030
TTM0.5011.658-1.157
YOY0.6762.142-1.466
5Y0.6112.307-1.696
10Y0.6092.370-1.761

1.4. Solvency of Stryker Corporation.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Stryker assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Stryker to Medical Devices industry mean.
  • A Debt to Asset Ratio of 0.53 means that Stryker assets are financed with 53.4% credit (debt) and the remaining percentage (100% - 53.4%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Stryker Corporation:

  • The MRQ is 0.534. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.535. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.534TTM0.535-0.001
TTM0.535YOY0.560-0.025
TTM0.5355Y0.565-0.030
5Y0.56510Y0.560+0.005
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5340.402+0.132
TTM0.5350.389+0.146
YOY0.5600.335+0.225
5Y0.5650.442+0.123
10Y0.5600.461+0.099
1.4.2. Debt to Equity Ratio

Measures if Stryker is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Stryker to the Medical Devices industry mean.
  • A Debt to Equity ratio of 114.7% means that company has €1.15 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Stryker Corporation:

  • The MRQ is 1.147. The company is able to pay all its debts with equity. +1
  • The TTM is 1.151. The company is able to pay all its debts with equity. +1
Trends
Current periodCompared to+/- 
MRQ1.147TTM1.151-0.005
TTM1.151YOY1.277-0.125
TTM1.1515Y1.307-0.155
5Y1.30710Y1.282+0.025
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ1.1470.559+0.588
TTM1.1510.560+0.591
YOY1.2770.479+0.798
5Y1.3070.614+0.693
10Y1.2820.674+0.608

2. Market Valuation of Stryker Corporation

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every €1 in earnings Stryker generates.

  • Above 15 is considered overpriced but always compare Stryker to the Medical Devices industry mean.
  • A PE ratio of 24.06 means the investor is paying €24.06 for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Stryker Corporation:

  • The EOD is 27.947. Based on the earnings, the company is overpriced. -1
  • The MRQ is 24.055. Based on the earnings, the company is fair priced.
  • The TTM is 34.184. Based on the earnings, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD27.947MRQ24.055+3.892
MRQ24.055TTM34.184-10.129
TTM34.184YOY43.328-9.144
TTM34.1845Y27.985+6.200
5Y27.98510Y24.653+3.331
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD27.947-1.021+28.968
MRQ24.055-1.704+25.759
TTM34.184-2.081+36.265
YOY43.328-2.980+46.308
5Y27.985-2.379+30.364
10Y24.653-1.726+26.379
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Stryker Corporation:

  • The EOD is 23.097. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The MRQ is 19.881. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The TTM is 46.592. Based on how much money comes from the company's main activities, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD23.097MRQ19.881+3.217
MRQ19.881TTM46.592-26.712
TTM46.592YOY100.428-53.836
TTM46.5925Y42.179+4.413
5Y42.17910Y30.128+12.051
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD23.097-0.981+24.078
MRQ19.881-1.578+21.459
TTM46.592-2.973+49.565
YOY100.428-6.179+106.607
5Y42.179-4.928+47.107
10Y30.128-5.060+35.188
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Stryker is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Devices industry mean).
  • A PB ratio of 5.92 means the investor is paying €5.92 for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of Stryker Corporation:

  • The EOD is 6.872. Based on the equity, the company is overpriced. -1
  • The MRQ is 5.915. Based on the equity, the company is overpriced. -1
  • The TTM is 6.163. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD6.872MRQ5.915+0.957
MRQ5.915TTM6.163-0.248
TTM6.163YOY5.557+0.606
TTM6.1635Y5.956+0.208
5Y5.95610Y5.796+0.160
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD6.8721.930+4.942
MRQ5.9152.372+3.543
TTM6.1632.444+3.719
YOY5.5573.205+2.352
5Y5.9563.893+2.063
10Y5.7964.245+1.551
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Stryker Corporation compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--1.6901.214+39%1.068+58%0.843+100%1.631+4%
Book Value Per Share--45.66343.441+5%39.171+17%35.810+28%32.632+40%
Current Ratio--1.5801.5840%1.913-17%2.099-25%2.125-26%
Debt To Asset Ratio--0.5340.5350%0.560-5%0.565-5%0.560-5%
Debt To Equity Ratio--1.1471.1510%1.277-10%1.307-12%1.282-11%
Dividend Per Share--0.7000.7000%0.645+8%0.587+19%0.537+30%
Eps--2.8072.033+38%1.448+94%1.393+101%1.396+101%
Free Cash Flow Per Share--3.3971.925+76%1.250+172%1.642+107%1.642+107%
Free Cash Flow To Equity Per Share--2.6940.993+171%0.790+241%0.930+190%0.930+190%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--98.714--------
Intrinsic Value_10Y_min--84.289--------
Intrinsic Value_1Y_max--6.980--------
Intrinsic Value_1Y_min--6.854--------
Intrinsic Value_3Y_max--23.190--------
Intrinsic Value_3Y_min--22.095--------
Intrinsic Value_5Y_max--42.077--------
Intrinsic Value_5Y_min--38.864--------
Market Cap119391491020.800+14%102764951321.600101751949904.000+1%82596235773.440+24%81124767986.560+27%72354472118.455+42%
Net Profit Margin--0.1970.152+29%0.128+54%0.127+55%0.139+41%
Operating Margin---0.093-100%0.190-100%0.188-100%0.197-100%
Operating Ratio--1.1461.174-2%1.209-5%1.194-4%1.143+0%
Pb Ratio6.872+14%5.9156.163-4%5.557+6%5.956-1%5.796+2%
Pe Ratio27.947+14%24.05534.184-30%43.328-44%27.985-14%24.653-2%
Price Per Share313.800+14%270.100267.438+1%217.090+24%213.223+27%190.171+42%
Price To Free Cash Flow Ratio23.097+14%19.88146.592-57%100.428-80%42.179-53%30.128-34%
Price To Total Gains Ratio131.319+14%113.031145.020-22%155.205-27%135.583-17%103.944+9%
Quick Ratio--0.4860.501-3%0.676-28%0.611-21%0.609-20%
Return On Assets--0.0290.021+39%0.016+76%0.017+73%0.019+53%
Return On Equity--0.0610.044+38%0.037+68%0.038+62%0.043+45%
Total Gains Per Share--2.3901.914+25%1.713+39%1.430+67%2.168+10%
Usd Book Value--18592904803.84017688409434.880+5%15949668337.280+17%14581275343.488+28%13287217683.383+40%
Usd Book Value Change Per Share--1.8081.299+39%1.143+58%0.902+100%1.745+4%
Usd Book Value Per Share--48.86846.491+5%41.921+17%38.324+28%34.923+40%
Usd Dividend Per Share--0.7490.7490%0.691+8%0.628+19%0.575+30%
Usd Eps--3.0042.176+38%1.549+94%1.491+101%1.494+101%
Usd Free Cash Flow--1382992919.040783995985.920+76%508997393.920+172%534997260.800+159%382140900.571+262%
Usd Free Cash Flow Per Share--3.6352.061+76%1.338+172%1.758+107%1.758+107%
Usd Free Cash Flow To Equity Per Share--2.8831.063+171%0.846+241%0.995+190%0.995+190%
Usd Market Cap127772773690.460+14%109979050904.376108894936787.261+1%88394491524.736+24%86819726699.217+27%77433756061.170+42%
Usd Price Per Share335.829+14%289.061286.212+1%232.330+24%228.191+27%203.521+42%
Usd Profit--1142994147.840791245948.800+44%589496981.760+94%559947133.056+104%563282830.263+103%
Usd Revenue--5814970227.2005124473762.560+13%4612226385.280+26%4264478165.760+36%3976229641.600+46%
Usd Total Gains Per Share--2.5572.048+25%1.833+39%1.530+67%2.320+10%
 EOD+4 -4MRQTTM+28 -5YOY+29 -65Y+30 -510Y+29 -6

3.2. Fundamental Score

Let's check the fundamental score of Stryker Corporation based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1527.947
Price to Book Ratio (EOD)Between0-16.872
Net Profit Margin (MRQ)Greater than00.197
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.486
Current Ratio (MRQ)Greater than11.580
Debt to Asset Ratio (MRQ)Less than10.534
Debt to Equity Ratio (MRQ)Less than11.147
Return on Equity (MRQ)Greater than0.150.061
Return on Assets (MRQ)Greater than0.050.029
Total3/10 (30.0%)

3.3. Technical Score

Let's check the technical score of Stryker Corporation based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5042.786
Ma 20Greater thanMa 50319.250
Ma 50Greater thanMa 100322.988
Ma 100Greater thanMa 200303.652
OpenGreater thanClose313.200
Total2/5 (40.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets39,912,000
Total Liabilities21,319,000
Total Stockholder Equity18,593,000
 As reported
Total Liabilities 21,319,000
Total Stockholder Equity+ 18,593,000
Total Assets = 39,912,000

Assets

Total Assets39,912,000
Total Current Assets12,518,000
Long-term Assets27,394,000
Total Current Assets
Cash And Cash Equivalents 2,971,000
Short-term Investments 82,000
Net Receivables 3,765,000
Inventory 4,843,000
Other Current Assets 857,000
Total Current Assets  (as reported)12,518,000
Total Current Assets  (calculated)12,518,000
+/-0
Long-term Assets
Property Plant Equipment 3,215,000
Goodwill 15,243,000
Intangible Assets 4,593,000
Long-term Assets Other 2,673,000
Long-term Assets  (as reported)27,394,000
Long-term Assets  (calculated)25,724,000
+/- 1,670,000

Liabilities & Shareholders' Equity

Total Current Liabilities7,921,000
Long-term Liabilities13,398,000
Total Stockholder Equity18,593,000
Total Current Liabilities
Short Long Term Debt 2,094,000
Accounts payable 1,517,000
Total Current Liabilities  (as reported)7,921,000
Total Current Liabilities  (calculated)3,611,000
+/- 4,310,000
Long-term Liabilities
Long term Debt 10,901,000
Long-term Liabilities Other 1,930,000
Long-term Liabilities  (as reported)13,398,000
Long-term Liabilities  (calculated)12,831,000
+/- 567,000
Total Stockholder Equity
Retained Earnings 16,771,000
Total Stockholder Equity (as reported)18,593,000
Total Stockholder Equity (calculated)16,771,000
+/- 1,822,000
Other
Capital Stock38,000
Common Stock Shares Outstanding 379,895
Net Debt 10,024,000
Net Invested Capital 31,588,000
Net Working Capital 4,597,000
Property Plant and Equipment Gross 6,344,000



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-31
> Total Assets 
20,517,000
21,292,000
21,485,000
22,197,000
22,133,000
21,570,000
22,084,000
27,229,000
25,937,000
26,354,000
26,659,000
30,167,000
29,440,000
31,483,000
32,286,000
34,330,000
33,455,000
33,698,000
34,145,000
34,631,000
36,137,000
36,032,000
35,983,000
36,884,000
36,830,000
37,409,000
38,042,000
39,912,000
39,912,00038,042,00037,409,00036,830,00036,884,00035,983,00036,032,00036,137,00034,631,00034,145,00033,698,00033,455,00034,330,00032,286,00031,483,00029,440,00030,167,00026,659,00026,354,00025,937,00027,229,00022,084,00021,570,00022,133,00022,197,00021,485,00021,292,00020,517,000
   > Total Current Assets 
7,889,000
8,478,000
7,710,000
7,993,000
7,851,000
7,413,000
7,918,000
9,733,000
7,888,000
8,185,000
8,566,000
11,360,000
10,736,000
12,801,000
13,545,000
9,707,000
8,979,000
9,032,000
9,460,000
10,017,000
8,725,000
8,825,000
9,318,000
10,275,000
10,155,000
10,151,000
11,045,000
12,518,000
12,518,00011,045,00010,151,00010,155,00010,275,0009,318,0008,825,0008,725,00010,017,0009,460,0009,032,0008,979,0009,707,00013,545,00012,801,00010,736,00011,360,0008,566,0008,185,0007,888,0009,733,0007,918,0007,413,0007,851,0007,993,0007,710,0008,478,0007,889,000
       Cash And Cash Equivalents 
3,213,000
3,649,000
2,592,000
2,542,000
2,179,000
1,641,000
1,918,000
3,616,000
1,674,000
1,754,000
1,948,000
4,337,000
3,964,000
6,539,000
7,083,000
2,943,000
2,238,000
2,241,000
2,563,000
2,944,000
1,458,000
1,044,000
1,420,000
1,844,000
1,671,000
1,401,000
1,860,000
2,971,000
2,971,0001,860,0001,401,0001,671,0001,844,0001,420,0001,044,0001,458,0002,944,0002,563,0002,241,0002,238,0002,943,0007,083,0006,539,0003,964,0004,337,0001,948,0001,754,0001,674,0003,616,0001,918,0001,641,0002,179,0002,542,0002,592,0003,649,0003,213,000
       Short-term Investments 
66,000
98,000
97,000
251,000
276,000
279,000
292,000
83,000
84,000
85,000
88,000
88,000
84,000
80,000
78,000
81,000
74,000
84,000
76,000
75,000
72,000
83,000
77,000
84,000
86,000
77,000
76,000
82,000
82,00076,00077,00086,00084,00077,00083,00072,00075,00076,00084,00074,00081,00078,00080,00084,00088,00088,00085,00084,00083,000292,000279,000276,000251,00097,00098,00066,000
       Net Receivables 
1,875,000
1,905,000
1,965,000
2,198,000
2,108,000
2,089,000
2,076,000
2,332,000
2,284,000
2,408,000
2,438,000
2,893,000
2,646,000
2,203,000
2,426,000
2,701,000
2,616,000
2,714,000
2,817,000
3,022,000
2,991,000
3,145,000
3,103,000
3,565,000
3,215,000
3,261,000
3,276,000
3,765,000
3,765,0003,276,0003,261,0003,215,0003,565,0003,103,0003,145,0002,991,0003,022,0002,817,0002,714,0002,616,0002,701,0002,426,0002,203,0002,646,0002,893,0002,438,0002,408,0002,284,0002,332,0002,076,0002,089,0002,108,0002,198,0001,965,0001,905,0001,875,000
       Inventory 
2,172,000
2,279,000
2,454,000
2,465,000
2,664,000
2,740,000
2,893,000
2,955,000
3,064,000
3,198,000
3,269,000
3,282,000
3,359,000
3,442,000
3,459,000
3,494,000
3,473,000
3,431,000
3,434,000
3,314,000
3,525,000
3,749,000
3,883,000
3,995,000
4,333,000
4,593,000
4,883,000
4,843,000
4,843,0004,883,0004,593,0004,333,0003,995,0003,883,0003,749,0003,525,0003,314,0003,434,0003,431,0003,473,0003,494,0003,459,0003,442,0003,359,0003,282,0003,269,0003,198,0003,064,0002,955,0002,893,0002,740,0002,664,0002,465,0002,454,0002,279,0002,172,000
       Other Current Assets 
563,000
19,000
37,000
15,000
14,000
74,000
38,000
43,000
108,000
102,000
196,000
185,000
130,000
24,000
23,000
16,000
94,000
54,000
74,000
146,000
98,000
194,000
185,000
29,000
23,000
819,000
950,000
857,000
857,000950,000819,00023,00029,000185,000194,00098,000146,00074,00054,00094,00016,00023,00024,000130,000185,000196,000102,000108,00043,00038,00074,00014,00015,00037,00019,000563,000
   > Long-term Assets 
0
0
0
0
0
0
0
0
18,049,000
18,169,000
18,093,000
18,807,000
18,704,000
18,682,000
18,741,000
24,623,000
24,476,000
24,666,000
24,685,000
24,614,000
27,412,000
27,207,000
26,665,000
26,609,000
26,675,000
27,258,000
26,997,000
27,394,000
27,394,00026,997,00027,258,00026,675,00026,609,00026,665,00027,207,00027,412,00024,614,00024,685,00024,666,00024,476,00024,623,00018,741,00018,682,00018,704,00018,807,00018,093,00018,169,00018,049,00000000000
       Property Plant Equipment 
1,655,000
1,758,000
1,852,000
1,975,000
2,054,000
2,101,000
2,178,000
2,291,000
2,652,000
2,744,000
2,822,000
2,951,000
2,607,000
2,933,000
2,930,000
3,175,000
3,134,000
3,142,000
3,146,000
3,252,000
3,283,000
3,272,000
2,798,000
2,970,000
3,037,000
3,082,000
3,106,000
3,215,000
3,215,0003,106,0003,082,0003,037,0002,970,0002,798,0003,272,0003,283,0003,252,0003,146,0003,142,0003,134,0003,175,0002,930,0002,933,0002,607,0002,951,0002,822,0002,744,0002,652,0002,291,0002,178,0002,101,0002,054,0001,975,0001,852,0001,758,0001,655,000
       Goodwill 
6,393,000
6,471,000
7,026,000
7,168,000
7,723,000
7,636,000
7,634,000
8,563,000
8,710,000
8,762,000
8,704,000
9,069,000
9,025,000
9,074,000
9,128,000
12,778,000
12,803,000
12,802,000
12,893,000
12,918,000
15,228,000
15,115,000
14,993,000
14,880,000
14,849,000
15,172,000
15,138,000
15,243,000
15,243,00015,138,00015,172,00014,849,00014,880,00014,993,00015,115,00015,228,00012,918,00012,893,00012,802,00012,803,00012,778,0009,128,0009,074,0009,025,0009,069,0008,704,0008,762,0008,710,0008,563,0007,634,0007,636,0007,723,0007,168,0007,026,0006,471,0006,393,000
       Long Term Investments 
7,000
11,000
10,000
5,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000005,00010,00011,0007,000
       Intangible Assets 
3,446,000
3,382,000
3,470,000
3,477,000
3,689,000
3,567,000
3,463,000
4,163,000
4,240,000
4,184,000
4,056,000
4,227,000
4,107,000
4,012,000
3,917,000
5,554,000
5,378,000
5,261,000
5,058,000
4,840,000
5,430,000
5,245,000
5,053,000
4,885,000
4,779,000
4,917,000
4,731,000
4,593,000
4,593,0004,731,0004,917,0004,779,0004,885,0005,053,0005,245,0005,430,0004,840,0005,058,0005,261,0005,378,0005,554,0003,917,0004,012,0004,107,0004,227,0004,056,0004,184,0004,240,0004,163,0003,463,0003,567,0003,689,0003,477,0003,470,0003,382,0003,446,000
       Long-term Assets Other 
0
0
0
0
0
0
0
0
1,171,000
1,223,000
1,287,000
1,369,000
1,428,000
1,499,000
1,540,000
2,009,000
2,066,000
2,114,000
2,128,000
2,263,000
2,359,000
2,419,000
2,431,000
2,464,000
2,567,000
2,648,000
2,616,000
2,673,000
2,673,0002,616,0002,648,0002,567,0002,464,0002,431,0002,419,0002,359,0002,263,0002,128,0002,114,0002,066,0002,009,0001,540,0001,499,0001,428,0001,369,0001,287,0001,223,0001,171,00000000000
> Total Liabilities 
10,813,000
11,257,000
11,060,000
12,217,000
12,910,000
12,110,000
12,224,000
15,499,000
14,244,000
14,411,000
14,344,000
17,360,000
16,325,000
18,729,000
19,300,000
21,246,000
19,953,000
19,878,000
19,967,000
19,754,000
21,091,000
20,358,000
19,520,000
20,268,000
19,935,000
20,048,000
20,137,000
21,319,000
21,319,00020,137,00020,048,00019,935,00020,268,00019,520,00020,358,00021,091,00019,754,00019,967,00019,878,00019,953,00021,246,00019,300,00018,729,00016,325,00017,360,00014,344,00014,411,00014,244,00015,499,00012,224,00012,110,00012,910,00012,217,00011,060,00011,257,00010,813,000
   > Total Current Liabilities 
2,554,000
3,552,000
3,258,000
3,485,000
4,800,000
4,046,000
4,153,000
4,807,000
3,713,000
3,946,000
3,921,000
4,400,000
4,162,000
4,405,000
4,689,000
5,041,000
3,953,000
4,252,000
4,449,000
4,549,000
4,408,000
4,404,000
4,571,000
6,303,000
5,866,000
6,584,000
7,458,000
7,921,000
7,921,0007,458,0006,584,0005,866,0006,303,0004,571,0004,404,0004,408,0004,549,0004,449,0004,252,0003,953,0005,041,0004,689,0004,405,0004,162,0004,400,0003,921,0003,946,0003,713,0004,807,0004,153,0004,046,0004,800,0003,485,0003,258,0003,552,0002,554,000
       Short-term Debt 
35,000
7,366,000
632,000
632,000
1,884,000
1,277,000
1,275,000
1,373,000
521,000
539,000
526,000
859,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000859,000526,000539,000521,0001,373,0001,275,0001,277,0001,884,000632,000632,0007,366,00035,000
       Short Long Term Debt 
35,000
7,366,000
632,000
632,000
1,884,000
1,277,000
1,275,000
1,373,000
521,000
539,000
526,000
859,000
1,103,000
1,110,000
1,119,000
761,000
15,000
6,000
22,000
7,000
214,000
7,000
8,000
1,191,000
1,204,000
1,798,000
2,308,000
2,094,000
2,094,0002,308,0001,798,0001,204,0001,191,0008,0007,000214,0007,00022,0006,00015,000761,0001,119,0001,110,0001,103,000859,000526,000539,000521,0001,373,0001,275,0001,277,0001,884,000632,000632,0007,366,00035,000
       Accounts payable 
2,519,000
427,000
458,000
487,000
529,000
561,000
563,000
646,000
619,000
616,000
659,000
675,000
736,000
635,000
647,000
810,000
767,000
864,000
934,000
1,129,000
1,084,000
1,160,000
1,213,000
1,413,000
1,366,000
1,326,000
1,296,000
1,517,000
1,517,0001,296,0001,326,0001,366,0001,413,0001,213,0001,160,0001,084,0001,129,000934,000864,000767,000810,000647,000635,000736,000675,000659,000616,000619,000646,000563,000561,000529,000487,000458,000427,0002,519,000
       Other Current Liabilities 
223,000
276,000
342,000
357,000
443,000
320,000
294,000
370,000
363,000
354,000
298,000
405,000
4,162,000
520,000
580,000
710,000
524,000
568,000
631,000
622,000
472,000
577,000
523,000
727,000
707,000
6,584,000
0
0
006,584,000707,000727,000523,000577,000472,000622,000631,000568,000524,000710,000580,000520,0004,162,000405,000298,000354,000363,000370,000294,000320,000443,000357,000342,000276,000223,000
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
10,531,000
10,465,000
10,423,000
12,960,000
12,163,000
14,324,000
14,611,000
16,205,000
16,000,000
15,626,000
15,518,000
15,205,000
16,683,000
15,954,000
14,949,000
13,965,000
14,069,000
13,464,000
12,679,000
13,398,000
13,398,00012,679,00013,464,00014,069,00013,965,00014,949,00015,954,00016,683,00015,205,00015,518,00015,626,00016,000,00016,205,00014,611,00014,324,00012,163,00012,960,00010,423,00010,465,00010,531,00000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
1,363,000
1,385,000
1,439,000
1,661,000
1,733,000
1,523,000
1,604,000
1,985,000
1,955,000
1,965,000
1,960,000
1,820,000
1,881,000
1,793,000
1,577,000
1,467,000
1,587,000
1,846,000
1,832,000
1,930,000
1,930,0001,832,0001,846,0001,587,0001,467,0001,577,0001,793,0001,881,0001,820,0001,960,0001,965,0001,955,0001,985,0001,604,0001,523,0001,733,0001,661,0001,439,0001,385,0001,363,00000000000
> Total Stockholder Equity
9,704,000
10,035,000
10,425,000
9,966,000
9,214,000
9,460,000
9,860,000
11,730,000
11,693,000
11,943,000
12,315,000
12,807,000
13,115,000
12,754,000
12,986,000
13,084,000
13,502,000
13,820,000
14,178,000
14,877,000
15,046,000
15,674,000
16,463,000
16,616,000
16,895,000
17,361,000
17,905,000
18,593,000
18,593,00017,905,00017,361,00016,895,00016,616,00016,463,00015,674,00015,046,00014,877,00014,178,00013,820,00013,502,00013,084,00012,986,00012,754,00013,115,00012,807,00012,315,00011,943,00011,693,00011,730,0009,860,0009,460,0009,214,0009,966,00010,425,00010,035,0009,704,000
   Common Stock
37,000
37,000
37,000
37,000
37,000
37,000
37,000
37,000
37,000
37,000
37,000
37,000
13,115,000
38,000
38,000
38,000
38,000
38,000
38,000
38,000
38,000
38,000
38,000
38,000
38,000
17,361,000
0
0
0017,361,00038,00038,00038,00038,00038,00038,00038,00038,00038,00038,00038,00038,00013,115,00037,00037,00037,00037,00037,00037,00037,00037,00037,00037,00037,00037,000
   Retained Earnings 
8,903,000
9,136,000
9,411,000
8,986,000
8,201,000
8,477,000
8,892,000
10,765,000
10,683,000
10,967,000
11,238,000
11,748,000
12,024,000
11,725,000
12,129,000
12,462,000
12,525,000
12,881,000
13,081,000
13,480,000
13,540,000
13,933,000
14,486,000
14,765,000
15,072,000
15,526,000
15,933,000
16,771,000
16,771,00015,933,00015,526,00015,072,00014,765,00014,486,00013,933,00013,540,00013,480,00013,081,00012,881,00012,525,00012,462,00012,129,00011,725,00012,024,00011,748,00011,238,00010,967,00010,683,00010,765,0008,892,0008,477,0008,201,0008,986,0009,411,0009,136,0008,903,000
   Accumulated Other Comprehensive Income 0000000000000000000000000000
   Capital Surplus 0000000000000000000000000000
   Treasury Stock0000000000000000000000000000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue20,498,000
Cost of Revenue-7,440,000
Gross Profit13,058,00013,058,000
 
Operating Income (+$)
Gross Profit13,058,000
Operating Expense-16,592,000
Operating Income3,906,000-3,534,000
 
Operating Expense (+$)
Research Development1,388,000
Selling General Administrative7,129,000
Selling And Marketing Expenses-
Operating Expense16,592,0008,517,000
 
Net Interest Income (+$)
Interest Income-
Interest Expense--
Other Finance Cost-0
Net Interest Income-
 
Pretax Income (+$)
Operating Income3,906,000
Net Interest Income-
Other Non-Operating Income Expenses-
Income Before Tax (EBT)3,673,0004,139,000
EBIT - interestExpense = 0
3,165,000
3,165,000
Interest Expense-
Earnings Before Interest and Taxes (EBIT)-3,673,000
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax3,673,000
Tax Provision-508,000
Net Income From Continuing Ops3,165,0003,165,000
Net Income3,165,000
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-233,0000
 

Technical Analysis of Stryker
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Stryker. The general trend of Stryker is BULLISH with 28.6% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Stryker's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (28.6%) Bearish trend (-28.6%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Stryker Corporation.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 320.10 < 324.60 < 333.60.

The bearish price targets are: 288.79 > 284.90 > 277.65.

Tweet this
Stryker Corporation Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Stryker Corporation. The current mas is .

The long score for the Moving Averages is 9/14.
The longshort score for the Moving Averages is 4/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Stryker Corporation Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Stryker Corporation. The current macd is -3.30020928.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Stryker price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Stryker. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Stryker price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Stryker Corporation Daily Moving Average Convergence/Divergence (MACD) ChartStryker Corporation Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Stryker Corporation. The current adx is 27.75.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -3/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Stryker shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bearish trend. The ADX is declining, the bearish trend is weakening. Could be a potential reversal to the upside. -2
Stryker Corporation Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Stryker Corporation. The current sar is 315.32.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Stryker Corporation Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Stryker Corporation. The current rsi is 42.79. The current phase is Correction in bull market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Correction in bull market: Moderate price decline, potential pause in the uptrend. Reassess the market, wait for signs of stabilization.
  • Trending up: The RSI is trending up. +1
Stryker Corporation Daily Relative Strength Index (RSI) ChartStryker Corporation Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Stryker Corporation. The current phase is Correction in bull market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Stryker price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Stryker Corporation Daily Stochastic Oscillator ChartStryker Corporation Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Stryker Corporation. The current cci is -64.65946526.

Stryker Corporation Daily Commodity Channel Index (CCI) ChartStryker Corporation Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Stryker Corporation. The current cmo is -13.86457493.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Stryker Corporation Daily Chande Momentum Oscillator (CMO) ChartStryker Corporation Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Stryker Corporation. The current willr is -55.67010309.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Stryker is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Stryker Corporation Daily Williams %R ChartStryker Corporation Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Stryker Corporation.

Stryker Corporation Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Stryker Corporation. The current atr is 3.8780995.

Stryker Corporation Daily Average True Range (ATR) ChartStryker Corporation Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Stryker Corporation. The current obv is 5,285.

Stryker Corporation Daily On-Balance Volume (OBV) ChartStryker Corporation Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Stryker Corporation. The current mfi is 53.24.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Stryker Corporation Daily Money Flow Index (MFI) ChartStryker Corporation Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Stryker Corporation.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-04STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-06MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-07STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-12MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-13SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-14STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-15SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-19CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-20STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-21CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-22CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-02SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-05MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-09CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-10BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-15ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-23RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-01-24SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-25MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-29WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-31MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-07STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-12MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-13STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-14ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-16MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-20ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-21MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-02-22SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-23CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-26RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-08WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-12SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-20CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-22CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-27CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-28CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-04-02STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-03SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-08STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-15CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-17STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-18STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-19STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-22RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside

6.3. Candlestick Patterns

Stryker Corporation Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Stryker Corporation based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5042.786
Ma 20Greater thanMa 50319.250
Ma 50Greater thanMa 100322.988
Ma 100Greater thanMa 200303.652
OpenGreater thanClose313.200
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Stryker with someone you think should read this too:
  • Are you bullish or bearish on Stryker? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Stryker? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Stryker Corporation

I send you an email if I find something interesting about Stryker Corporation.


Comments

How you think about this?

Leave a comment

Stay informed about Stryker Corporation.

Receive notifications about Stryker Corporation in your mailbox!